Pretransplant laboratory abnormalities, particularly a high MELD score (>27), hyponatremia, elevated BNP, and anemia (Hb <8 g/dL), have also been implicated [12,13,16,20,21]. This evidence concerns the gene GSTM1 and Hyponatremia.